Literature DB >> 3652488

Incidence of familial dysautonomia in Israel 1977-1981.

C Maayan1, E Kaplan, S Shachar, O Peleg, S Godfrey.   

Abstract

The incidence of all diagnosed cases of familial dysautonomia in Israel among Ashkenazi Jews from 1977-1981 was 27/100,000 or 1/3703. This incidence is higher than that previously reported in Israel in 1967 or 8.3/100,000 (1/12,048) (Moses et al. 1967). It is also higher than that of North American Ashkenazi Jews in 1970, when the rate was 5-10/100,000 (1/10,000-20,000) (Brunt & McKusick 1970). This higher incidence could be explained by current awareness of the diagnosis, or by the emergence of more cases.

Entities:  

Mesh:

Year:  1987        PMID: 3652488     DOI: 10.1111/j.1399-0004.1987.tb03334.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  32 in total

Review 1.  Hereditary Sensory and Autonomic Neuropathies: Adding More to the Classification.

Authors:  Coreen Schwartzlow; Mohamed Kazamel
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-20       Impact factor: 5.081

2.  Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia.

Authors:  Matthew M Hims; El Chérif Ibrahim; Maire Leyne; James Mull; Lijuan Liu; Conxi Lazaro; Ranjit S Shetty; Sandra Gill; James F Gusella; Robin Reed; Susan A Slaugenhaupt
Journal:  J Mol Med (Berl)       Date:  2007-01-06       Impact factor: 4.599

3.  24-hour ambulatory blood pressure monitoring in children with familial dysautonomia.

Authors:  Naomi Nussinovitch; Moshe Nussinovitch; Edna Peleg; Talma Rosenthal
Journal:  Pediatr Nephrol       Date:  2005-02-16       Impact factor: 3.714

4.  Lack of migraine in headaches of familial dysautonomia patients.

Authors:  Boris Shihman; Israel Steiner; Ivelin Yovchev; Channa Maayan
Journal:  J Neural Transm (Vienna)       Date:  2012-10-09       Impact factor: 3.575

5.  Precise genetic mapping and haplotype analysis of the familial dysautonomia gene on human chromosome 9q31.

Authors:  A Blumenfeld; S A Slaugenhaupt; C B Liebert; V Temper; C Maayan; S Gill; D E Lucente; M Idelson; K MacCormack; M A Monahan; J Mull; M Leyne; M Mendillo; T Schiripo; E Mishori; X Breakefield; F B Axelrod; J F Gusella
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

Review 6.  The molecular basis of familial dysautonomia: overview, new discoveries and implications for directed therapies.

Authors:  Berish Y Rubin; Sylvia L Anderson
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

Review 7.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

8.  Enriched population of PNS neurons derived from human embryonic stem cells as a platform for studying peripheral neuropathies.

Authors:  Moran Valensi-Kurtz; Sharon Lefler; Malkiel A Cohen; Michal Aharonowiz; Rachel Cohen-Kupiec; Anton Sheinin; Uri Ashery; Benjamin Reubinoff; Miguel Weil
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

9.  Increased globotriaosylceramide in familial dysautonomia.

Authors:  P Strasberg; H Yeger; I Warren
Journal:  Lipids       Date:  1992-12       Impact factor: 1.880

10.  Exclusion of familial dysautonomia from more than 60% of the genome.

Authors:  A Blumenfeld; F B Axelrod; J A Trofatter; C Maayan; D E Lucente; S A Slaugenhaupt; C B Liebert; L J Ozelius; J L Haines; X O Breakefield
Journal:  J Med Genet       Date:  1993-01       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.